Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06917339 · ClinicalTrials.gov registry record
Retrospective Analyses of TrakStar Database
A clinical trial of Depression and Obsessive - Compulsive Disorder, sponsored by Neuronetics.
- Recruiting
- Registry status
- 156,000
- Enrollment target
- 1
- Study location
NCT06917339 is a study of Depression and Obsessive - Compulsive Disorder that is actively recruiting participants, run by Neuronetics. The registered enrollment target is 156,000 participants, above the 556-participant average among 679 other Depression trials with a reported enrollment target (27958% higher). The trial reports 1 study location across 1 state.
The verdict
NCT06917339, a study of Depression and Obsessive - Compulsive Disorder, is actively recruiting participants, sponsored by Neuronetics.
- RECRUITING
- Registry status
- 156,000 participants
- Enrollment target
- 1
- Study location
Study Summary
In this study, real-world data will be used to better understand the effects patient characteristics, symptoms and TMS protocol parameters have on clinical outcomes with NeuroStar TMS.
Conditions Studied
Interventions
- DEVICE NeuroStar Advanced TMS Therapy System
Study Locations (1)
Pennsylvania
- Neuronetics - Malvern
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 156,000 participants |
| Start Date | 2025-02-25 |
| Est. Completion | 2035-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06917339
The ClinicalTrials.gov registry entry for NCT06917339 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 156,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 556-participant average among 679 other Depression trials with a reported enrollment target (27958% higher). The listed sponsor is Neuronetics, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Depression appearing as the primary indexed condition, and to 1 intervention - of which NeuroStar Advanced TMS Therapy System is the first listed.
NCT06917339 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT06917339 about?
NCT06917339 is a clinical study titled "Retrospective Analyses of TrakStar Database". In this study, real-world data will be used to better understand the effects patient characteristics, symptoms and TMS protocol parameters have on clinical outcomes with NeuroStar TMS.
What is the current status of trial NCT06917339?
This trial is currently recruiting. The enrollment target is 156,000 participants. The study started on 2025-02-25. Estimated completion is 2035-12.
What conditions does trial NCT06917339 study?
This clinical trial studies the following conditions: Depression, Obsessive - Compulsive Disorder, Anxiety Depression.
What interventions are being tested in trial NCT06917339?
The interventions under investigation include: NeuroStar Advanced TMS Therapy System (DEVICE).
Who is sponsoring clinical trial NCT06917339?
This trial is sponsored by Neuronetics, which has 11 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06917339 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Reaching Out to Distressed Medical Residents, Fellows and Faculty
RECRUITING · NA
-
Depression and Driving
RECRUITING
-
Neuropharmacologic Imaging and Biomarker Assessments of Response to Acute and Repeated-Dosed Ketamine Infusions in Major Depressive Disorder
RECRUITING · Phase 1
-
Sleep to Reduce Incident Depression Effectively in Peripartum
RECRUITING · Phase 2
-
PET Imaging of Cyclooxygenase in Participants With Major Depressive Disorder (MDD)
RECRUITING · Phase 1
-
Identifying and Treating Depression in the Orthopaedic Trauma Population
RECRUITING · Phase 4
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.